BioCentury
ARTICLE | Company News

Ipsen management update

October 18, 2010 7:00 AM UTC

Ipsen Group (Euronext:IPN), Paris, France Business: Cancer, Endocrine, Neurology Departing: Jean-Luc Belingard as chairman and CEO, effective Nov. 22; he is replaced by Marc de Garidel, VP of the Sout...